drugset / Trial / NCT02081560

Colistin Pharmacokinetics in Continuous Renal Replacement Therapy

NCT02081560

Phase 4 Unknown 10 enrolled University of Zurich
NaSingle-groupOpen-labelTreatment

Summary

The blood concentration of the antibiotic colistin is determined in patients in whom kidney function is reduced such that a renal replacement therapy is needed. Hypothesis:no dose reduction is needed in patients undergoing continuous renal replacement therapy over 24h because colistin is sufficiently removed by this procedure.

Timeline

Start
2013-11
Primary completion
2015-07
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Colistin Other / unclassified 3e+06 iu Intravenous

Indications